Lv51
830 积分 2023-07-17 加入
Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment
2小时前
待确认
The influence of ACPA status and characteristics on the course of RA
2小时前
待确认
Efficacy of biologics in atopic dermatitis
4天前
已完结
A Laboratory Model to Study T-Cell Motility
9天前
已完结
Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving Omalizumab (Xolair) therapy
10天前
已完结
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
15天前
已完结
Inhibition of allergic reactions with antibodies to IgE
18天前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
25天前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
25天前
已完结
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
25天前
已完结
皖公网安备34019202002308
